g(m2)-ganglioside and Brain-Injuries

g(m2)-ganglioside has been researched along with Brain-Injuries* in 2 studies

Other Studies

2 other study(ies) available for g(m2)-ganglioside and Brain-Injuries

ArticleYear
Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury.
    ACS chemical neuroscience, 2013, Apr-17, Volume: 4, Issue:4

    Explosive detonations generate atmospheric pressure changes that produce nonpenetrating blast induced "mild" traumatic brain injury (bTBI). The structural basis for mild bTBI has been extremely controversial. The present study applies matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging to track the distribution of gangliosides in mouse brain tissue that were exposed to very low level of explosive detonations (2.5-5.5 psi peak overpressure). We observed major increases of the ganglioside GM2 in the hippocampus, thalamus, and hypothalamus after a single blast exposure. Moreover, these changes were accompanied by depletion of ceramides. No neurological or brain structural signs of injury could be inferred using standard light microscopic techniques. The first source of variability is generated by the Latency between blast and tissue sampling (peak intensity of the blast wave). These findings suggest that subtle molecular changes in intracellular membranes and plasmalemma compartments may be biomarkers for biological responses to mild bTBI. This is also the first report of a GM2 increase in the brains of mature mice from a nongenetic etiology.

    Topics: Animals; Blast Injuries; Brain Injuries; Ceramides; Disease Models, Animal; G(M2) Ganglioside; Gangliosides; Male; Mice; Mice, Inbred ICR; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2013
Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
    Human molecular genetics, 1996, Volume: 5, Issue:1

    We have generated mouse models of human Tay-Sachs and Sandhoff diseases by targeted disruption of the Hexa (alpha subunit) or Hexb (beta subunit) genes, respectively, encoding lysosomal beta-hexosaminidase A (structure, alpha) and B (structure, beta beta). Both mutant mice accumulate GM2 ganglioside in brain, much more so in Hexb -/- mice, and the latter also accumulate glycolipid GA2. Hexa -/- mice suffer no obvious behavioral or neurological deficit, while Hexb -/- mice develop a fatal neurodegenerative disease, with spasticity, muscle weakness, rigidity, tremor and ataxia. The Hexb -/- but not the Hexa -/- mice have massive depletion of spinal cord axons as an apparent consequence of neuronal storage of GM2. We propose that Hexa -/- mice escape disease through partial catabolism of accumulated GM2 via GA2 (asialo-GM2) through the combined action of sialidase and beta-hexosaminidase B.

    Topics: Animals; Base Sequence; beta-N-Acetylhexosaminidases; Brain Chemistry; Brain Injuries; Disease Models, Animal; Female; G(M2) Ganglioside; Gene Targeting; Glycosphingolipids; Hexosaminidase A; Hexosaminidase B; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Organ Specificity; Phenotype; RNA, Messenger; Sandhoff Disease; Spinal Cord; Tay-Sachs Disease

1996